Core Muscle Function and Postural Control in Lower Extremity Amputees
usg
Investigation of the Relationship Between Core Muscle Function Assessed by Ultrasonography and Postural Control During Different Activities in Individuals With Lower Extremity Amputation
1 other identifier
observational
32
1 country
1
Brief Summary
The primary aim of this study is to determine the effect of amputation on core muscle groups by comparing core muscle thickness in individuals with lower extremity amputation to both their intact side and a healthy control group using ultrasonographic assessment. The secondary aim is to investigate the relationship between core muscle thickness and postural stability outcomes during different activities in individuals with lower extremity amputation, and to determine the effect of core muscles on postural control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 4, 2025
CompletedFirst Submitted
Initial submission to the registry
October 1, 2026
CompletedFirst Posted
Study publicly available on registry
October 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 4, 2027
October 15, 2026
October 1, 2026
1.6 years
October 1, 2026
October 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Diaphragm Thickening Fraction
Diaphragm thickness will be assessed bilaterally at the zone of apposition using B-mode ultrasonography at the end of quiet expiration and during deep inspiration. Diaphragm thickening fraction will be calculated as \[(thickness during deep inspiration - thickness at the end of quiet expiration) / thickness at the end of quiet expiration\] × 100 and reported as a percentage (%). Three high-quality measurements will be obtained for each side, and the mean value will be used for analysis. Bilateral measurements will be used for side and group comparisons.
Day 1
Transversus Abdominis Activation Ratio
Transversus abdominis muscle thickness will be assessed bilaterally using B-mode ultrasonography at the end of quiet expiration at rest and during the abdominal drawing-in maneuver. The activation ratio will be calculated by dividing muscle thickness during the abdominal drawing-in maneuver by muscle thickness at rest. Three high-quality measurements will be obtained for each side, and the mean value will be used for analysis. The activation ratio is dimensionless. Bilateral measurements will be used for side and group comparisons.
Day 1
Internal Oblique Activation Ratio
Internal oblique muscle thickness will be assessed bilaterally using B-mode ultrasonography at the end of quiet expiration at rest and during the abdominal drawing-in maneuver. The activation ratio will be calculated by dividing muscle thickness during the abdominal drawing-in maneuver by muscle thickness at rest. Three high-quality measurements will be obtained for each side, and the mean value will be used for analysis. The activation ratio is dimensionless. Bilateral measurements will be used for side and group comparisons.
Day 1
Secondary Outcomes (16)
Standing Postural Sway
Day 1
Percentage of Remaining Limb
Day 1
Prosthesis Awareness
Day 1
Fear of Falling
Day 1
Reaction Time During Limits of Stability Test
Day 1
- +11 more secondary outcomes
Study Arms (2)
1) Experimental Group: individual with amputation
Participants in the amputee group will include individuals aged 20-60 years with unilateral transtibial or transfemoral amputation, classified as K1-K3 functional level, who are able to stand without assistive devices and use their prosthesis for at least 4 hours per day. All participants must provide voluntary informed consent. Individuals will be excluded if they have severe phantom or residual limb pain (≥6 on the Numeric Rating Scale), bilateral lower extremity amputation, or a body mass index greater than 30.
Control Group: Healthy Subjects
The control group will consist of healthy individuals with demographic characteristics similar to the amputee group and without a regular exercise habit. Individuals will be excluded if they have central or peripheral vestibular disorders, lower extremity joint contractures, use medications affecting balance, or have a body mass index greater than 30.
Eligibility Criteria
Amputees who applied to our faculty for prosthesis construction and control, and healthy individuals from relatives of the researcher reached by snowball method will constitute the sample of the study.
You may qualify if:
- Being between 20-60 years of age
- Having a unilateral transtibial or transfemoral amputation
- Being at K1-K3 functional activity level
- Being able to stand without the use of assistive devices
- Using a prosthesis for at least 4 hours per day
- Volunteering to participate in the study
You may not qualify if:
- Having phantom or residual limb pain ≥6 according to the Numeric Rating Scale
- Having bilateral lower extremity amputation
- Having a Body Mass Index greater than 30
- For the Healthy Control Group
- Healthy individuals with demographic characteristics similar to the amputee group
- Not having a regular exercise habit
- Having central or peripheral vestibular disorders
- Having lower extremity joint contractures
- Using medications that affect balance
- Having a Body Mass Index greater than 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylül University Faculty of Physical Therapy and Rehabilitation 15 July Health Campus, Mithatpaşa Street No: 56/15 İnciraltı 35340 - İZMİR
Balçova, İzmir, 35130, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 1, 2026
First Posted
October 15, 2026
Study Start
December 4, 2025
Primary Completion (Estimated)
July 4, 2027
Study Completion (Estimated)
December 4, 2027
Last Updated
October 15, 2026
Record last verified: 2026-10